Skip to content

ACADACADIA PHARMACEUTICALS INC

CUSIP 004225108 · common stock

4 tracked investors held ACADIA PHARMACEUTICALS INC (ACAD) at the end of Q3 2026, worth $881.2M in total. The largest holder was Julian Baker, with 4.1% of its portfolio. Joel Greenblatt opened a new position this quarter.

Holders · Q3 2026
4
New holders
1
Value held
$881.2M
Quarter-end price (est.)
$20.15

Investors holding ACAD · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
4.11%42,912,904$864.7MHOLD
Ken Fisher
Fisher Asset Management, LLC
0.00%711,352$14.3MADD+1.7%
Chuck Royce
Royce & Associates LP
0.02%93,193$1.9MADD+1.4%
Joel Greenblatt
Gotham Asset Management, LLC
0.00%14,788$298KNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Adar1 Capital Management0.05%38,955$985.6KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026411$881.2M$20.15
Q2 2026421$1.1B$25.30
Q1 2026300$972.1M$22.26
Q4 2025300$1.2B$26.71